August 16, 2019 / 6:39 AM / 2 months ago

BRIEF-Celon Pharma Completes Administration Of Drug Candidate In Phase I Clinical Test

Aug 16 (Reuters) - Celon Pharma SA:

* SAID ON THURSDAY THAT IT HAS COMPLETED ADMINISTRATION OF DRUG CANDIDATE IN PHASE I OF CLINICAL TEST OF A DRUG BASED ON PDE10A INHIBITOR, DEVELOPED IN THE TREATMENT OF PSYCHOTIC AND NEUROMOTOR DISORDERS - CPL500036

* SAID DURING THE TEST THE DRUG WAS WELL TOLERATED AND SHOWED DESIRED PHARMACOKINETICS BOTH AFTER SINGLE AND REPEATED ADMINISTRATION

* SAID IT IS CURRENTLY ANALYSING LAST DATA AND HAS ALREADY STARTED PREPARING FOR PHASE II OF CLINICAL TEST WITH PARTICIPATION OF PATIENTS

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below